HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies. Shi H, Feng Y, Guo T, Shou W, et al. Breast Cancer (Dove Med Press) 2026;18:612951.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shi H, Feng Y, Guo T, Shou W, et al. HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies. Breast Cancer (Dove Med Press) 2026;18:612951.
PMID: 42311837